The CDC in the US acknowledges that “an elevated risk for myocarditis among mRNA COVID-19 vaccine recipients has been observed, particularly among males aged 12–29 years”, though this is downplayed in part because there is also “an association between COVID-19 and myocarditis”.
Share this post
COVID vaccine safety. Myocarditis
Share this post
The CDC in the US acknowledges that “an elevated risk for myocarditis among mRNA COVID-19 vaccine recipients has been observed, particularly among males aged 12–29 years”, though this is downplayed in part because there is also “an association between COVID-19 and myocarditis”.